This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Whether they are digital health, medical device, biotech, or pharma companies, healthtech has costly and inefficient sales processes that often stem from a lack of foundational data & insights to reach the right target markets efficiently and effectively. physicians, physician groups, hospitals, health systems, etc).
Biotech Showcase is true to its name – great companies are highlighted.” Tina Elder, Global Managing Director, EBD Group US, said, “Biotech Showcase has once again shown itself to be the premiere destination for innovators and partners to access a powerful network of industry decision-makers, media and top investors.
After escaping the revolution in Iran, Sean Khozin found his way to the United States, harmonizing his passion for patients and data into a career that’s led him into startups, the FDA, and most recently J&J, where he’s now Global Head of Data Strategy – all while pursuing his love of music. The phrase “it’s […].
For a skydiver who’s motto is “Just jump out and go”, the journey from chasing down Sandanista kidnappers to driving Disney strategy to genomics pioneer sounds sort of rational. Lisa Alderson, founder and CEO of Genome Medical, is one of those special someones who thrives on adrenaline and channels it to great effect. Lisa went […].
As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. We look for similar customer-oriented ethos and patient-centric mindsets in our partnerships,” said Kim Kushner, Chief Business Officer, SSI Strategy. Learn more at koneksahealth.com.
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges.
One of the biggest gambles in biotech history is about to be tested on Wall Street. In its prospectus, Moderna set an initial target of $500 million for the offering, which would make it the largest biotech IPO in history. This has all been part of a high-stakes strategy by Moderna and its backers. We believe we can.”
While giants like UnitedHealth or biotech stars like Vertex Pharmaceuticals often dominate headlines, Doximitys niche focus and execution have propelled it ahead. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today! Subscribe Today!
ADT Biotech 7.5 Mesa Biotech (Thermo Fisher) 7.42 Mesa Biotech (Thermo Fisher) 7.42 The research provides an in-depth look at the current and future market participants driving growth in this sector. Announces Two Acquisitions 6.36 Nigerian Govt Approves Alere HIV Self-Test Kit 6.37 Tasso scores $6.1M 1DropDiagnostics 7.2
Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. This is down from 6.5x Subscribe Today!
This activity sent pharma and biotech companies scrambling to hire DE&I officers and related patient advocacy, engagement, and experience personnel as they came to terms with this foreign notion of actually collaborating with real, live patients. She is currently contracted by Parexel as their first Patient Ambassador.
As our ability to utilize data to demonstrate positive clinical outcomes continues to be enhanced through technology, healthcare and biotech companies are under increasing pressure to demonstrate positive clinical outcomes and patient benefits from these investments.
So much so that, according to Gartner Prediction, by 2025, 25% of Healthcare Delivery Organizations will include formalized digital twin initiatives within their digital transformation strategy as it enables the development of digital representations of real-world assets.
The increasing prevalence of these conditions is driving demand for innovative solutions and improved management strategies. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today! Subscribe Today!
Strategies for assessing data completeness and developing signal quality indices, as demonstrated for example in epilepsy studies, contribute to enhancing the credibility of DHT-derived measures. The company will supply solutions to AstraZeneca while extending services to pharma, biotech companies, and clinical research organizations.
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients.
About Koneksa Koneksa is a healthcare technology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. Our evidence-based biomarker solutions enable efficient clinical trial designs to help innovative therapies reach patients faster.
This moment presents a unique opportunity for B Capital to leverage our dedicated healthcare capital and active investment strategy to find and support companies advancing the healthcare sector.” Dr. Mittendorff joined B Capital in April 2021 to lead Healthcare Fund I and B Capital’s broader healthcare initiatives globally.
What’s underneath that macro “healthcare” index number of 67 is a precipitous decline in the past year for Americans’ trust in hospitals, compared with biotech, pharma, consumer healthcare, and even health insurance — all of which grew in trust between 2018 and 2019, but not so with the hospital segment of U.S.
Edelman’s health industry segments for this study are pharma, consumer health, insurance, biotech/life science, and hospitals. Consumer health went opposite, up 7 points, biotech up 3, insurance up 8, pharma up 6. consumer trust across all of these segments increased a bit – except for hospitals, which fell 7 points.
“In only seven years, Health+Commerce has built a highly respected organization providing strategic programs that reach clinician, investor and consumer audiences in the multibillion-dollar medtech, biotech and digital health sectors. We look forward to supporting the agency as it continues on its growth trajectory.”
Bilateral partnerships of this nature not only bolster our members’ businesses on the international stage, but also spotlight the robust offerings of our local ecosystem to enterprises from other growing biotech regions such as Florida,” commented Benoit Larose, CEO of BIOQuébec.
QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners. market , along with a series of executive appointments including David Dornstreich as Chief Commercial Officer and Co-Founder Arnon Horev as Chief Strategy and Operations Officer.
Players Include 1DropDiagnostics, Abbott Laboratories, Ador Diagnostics, ADT Biotech and Akonni Biosystems DUBLIN–(BUSINESS WIRE)–The “OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct to Consumer. Forecasts by Application by Channel by Country.
EVERSANA INTOUCH Healthware joins five full-service affiliates and four specialty affiliates serving clients across the globe with world-class strategy, next-generation branding and creative, and innovative solutions to propel the future of life science marketing.
Streamlining Due Diligence with AI: AI technologies will likely be crucial in conducting efficient and thorough due diligence, examining potential M&A targets in the biotech industry for their scientific innovation, financial stability, and market compatibility. Dave Latshaw, CEO at BioPhy 1.
Global marketing strategy and marketing consulting firm Simon-Kucher & Partners surveyed more than 120 managers from the pharma and medtech industries in August and September of this year to […].
Founded in 2015 and headquartered in New York, m+a offers full-service capabilities to a diverse group of blue-chip pharma, biotech, and digital health companies across a range of therapeutic categories, including rare diseases, mental health, oncology, CNS, dermatology, and more. Terms of the transaction were not disclosed.
Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. link] HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Paige.AI : A medical imaging company specialising in AI-powered diagnostics. Why Healthcare?
About Solas BioVentures Solas BioVentures invests exclusively in the life science industry, focusing on early-stage biotech, medtech and digital health companies. This strategy has been validated through a number of companies in both Fund I and II and the Colucid Pharmaceuticals exit.
Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He Contacts Rob Wilson – Vice President of Marketing Strategy rob.wilson@vivosense.com Tel: +1 858-876-8486 For more information, visit www.vivosense.com. We are on Twitter.
About Koneksa Koneksa is a healthcare technology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. Our evidence-based biomarker solutions enable efficient clinical trial designs to help innovative therapies reach patients faster.
Sharpless is a proponent of big data and previously founded two biotech companies. New National Health Security Strategy Released by HHS. As part of a federal law that requires the development of a National Health Security Strategy every four years, U.S. CMS Publishes New National Health Expenditures Data.
European medical regulators have greenlighted Lilly’s long-acting insulin for sale in the EU , according to Fierce Biotech. Researchers hope this strategy, which is currently 70% accurate, can soon be utilized to uncover diabetes in people living in countries with poor primary care infrastructure…and great bee supplies.
The flexibility of its strategy allows RA Capital to provide seed funding to startups and to lead private, IPO, and follow-on financings for its portfolio companies, allowing management teams to drive value creation from inception through commercialization. For more information, please visit www.rac a p.com.
This investment is perfectly in line with MACSF’s strategy of helping to improve the world of healthcare. Today, the company has gathered €4.5 “This fundraising is a decisive step for BrainTale, and enables us to look forward with ambition to our next development milestones.
From digital health to biotech, from Pre-Seed to Series B, and from first-time founders to serial entrepreneurs, this cohort is indeed eclectic. . “The 2024 companies represent the very best of mental health innovation and we are excited to welcome them into the One Mind Accelerator,” said Brandon Staglin, President of One Mind.
Both Wellington and Forbion are visionaries and highly experienced biotech investors, and we look forward to working closely with them in our efforts to transform the gene editing landscape.” “Our billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. Forbion manages well over EUR 2.3
This commitment has resulted in a national digital health strategy and the creation of the Digital Health & Care Innovation Centre (DHI), which supports collaboration and innovation in the sector. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.
Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally.
Buy Side, Sell Side, Strategy and Growth mandates - Email , lloyd@healthcare.digital Scotland's top ten tech start-ups - HealthTech related companies "At the top is Glasgow-based Amphista Therapeutics, which raised $50m in 2022. Buy Side, Sell Side, Strategy and Growth mandates - Email , lloyd@healthcare.digital
Somer Baburek, CEO of Hera Biotech, which directs medical advances to address unmet needs in women’s health, wrote in the Clinical Leader : “I haven’t seen a lot of behaviour change on the industry side. We need to be creative, to learn and to measure the effectiveness of our diversity strategies.
WeDoctor's partnerships with hospitals and clinics in Italy and Spain are part of its strategy to expand its presence in Europe. These partnerships are part of Alibaba Health's strategy to expand its presence in Europe and to develop digital health solutions that can improve the quality of care for patients.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
124 
Let's personalize your content